Related Experiment Video

Updated: Aug 30, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Phenylephrine increases pulmonary blood flow in children with tetralogy of Fallot

Katsuya Tanaka1, Hiroshi Kitahata, Shinji Kawahito

  • 1Department of Anaesthesiology, Tokushima University School of Medicine, Tokushima, Japan. ktanaka@mcw.edu

Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|November 18, 2003
PubMed

Insights

Increasing blood pressure with phenylephrine improved oxygen levels in children with tetralogy of Fallot. This suggests that higher blood pressure boosts pulmonary blood flow, enhancing arterial oxygen saturation in these patients.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Physiology
  • Congenital Heart Disease

Background:

  • Tetralogy of Fallot (TOF) is a complex congenital heart defect.
  • Improved blood pressure has been anecdotally linked to better oxygenation in TOF patients.
  • Prospective studies are needed to confirm the relationship between blood pressure and pulmonary blood flow in TOF.

Purpose of the Study:

  • To investigate if phenylephrine-induced hypertension increases pulmonary blood flow in children with TOF.
  • To determine if this increase in pulmonary blood flow leads to improved arterial oxygenation.

Main Methods:

  • 14 children with TOF (2-32 months) received intravenous phenylephrine.
  • Transesophageal pulsed Doppler recorded pulmonary venous flow (PVF) velocity.
  • Arterial blood gases and hemodynamics were measured; minute distance (MD) was calculated.

Main Results:

  • Phenylephrine increased mean arterial blood pressure (54 to 73 mmHg).
  • Significant increases in SaO(2) (92.0% to 95.0%) and PVF minute distance (1318 to 1533 cm x min(-1)) were observed.
  • A strong correlation (r=0.72) existed between changes in MD and SaO(2).

Conclusions:

  • Phenylephrine-induced hypertension increases pulmonary blood flow in tetralogy of Fallot.
  • This enhanced pulmonary blood flow is a likely mechanism for improved arterial oxygenation in TOF.
  • The findings support a potential therapeutic role for blood pressure management in TOF.
Abstract

Related Concept Videos

Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...